158 related articles for article (PubMed ID: 19766114)
1. TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity.
Wu S; Hultquist A; Hydbring P; Cetinkaya C; Oberg F; Larsson LG
Exp Cell Res; 2009 Nov; 315(18):3099-111. PubMed ID: 19766114
[TBL] [Abstract][Full Text] [Related]
2. Mad 1 inhibits cell growth and proliferation but does not promote differentiation or overall survival in human U-937 monoblasts.
Hultquist A; Cetinkaya C; Wu S; Castell A; Erlandsson A; Larsson LG
Mol Cancer Res; 2004 Aug; 2(8):464-76. PubMed ID: 15328373
[TBL] [Abstract][Full Text] [Related]
3. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
4. The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis.
Werner S; Beer HD; Mauch C; Lüscher B; Werner S
Oncogene; 2001 Nov; 20(51):7494-504. PubMed ID: 11709721
[TBL] [Abstract][Full Text] [Related]
5. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
Edmiston JS; Yeudall WA; Chung TD; Lebman DA
Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
[TBL] [Abstract][Full Text] [Related]
6. Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence.
Reimann M; Lee S; Loddenkemper C; Dörr JR; Tabor V; Aichele P; Stein H; Dörken B; Jenuwein T; Schmitt CA
Cancer Cell; 2010 Mar; 17(3):262-72. PubMed ID: 20227040
[TBL] [Abstract][Full Text] [Related]
7. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
[TBL] [Abstract][Full Text] [Related]
8. Expression of Mad1 protein inhibits proliferation of cancer cells and inversely correlated with Myc protein expression in primary gastric cancer.
Han S; Park K; Kim HY; Lee MS; Kim HJ; Kim YD
Oncol Rep; 1999; 6(3):569-74. PubMed ID: 10203593
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity.
Harms KL; Chen X
Cancer Res; 2007 Apr; 67(7):3145-52. PubMed ID: 17409421
[TBL] [Abstract][Full Text] [Related]
10. Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest.
Acosta JC; Ferrándiz N; Bretones G; Torrano V; Blanco R; Richard C; O'Connell B; Sedivy J; Delgado MD; León J
Mol Cell Biol; 2008 Dec; 28(24):7286-95. PubMed ID: 18838534
[TBL] [Abstract][Full Text] [Related]
11. Involvement of c-Myc in growth inhibition of Hep 3B human hepatoma cells by a vitamin K analog.
Ge L; Wang Z; Wang M; Kar S; Carr BI
J Hepatol; 2004 Nov; 41(5):823-9. PubMed ID: 15519656
[TBL] [Abstract][Full Text] [Related]
12. [Expression and mutation of myc antagonist genes Mad1, Mxi1 and Rox in leukemia cells].
Suo XH; Pan L; Yao L; Zhang XJ; Niu ZY; Dong ZR
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):745-9. PubMed ID: 18457265
[TBL] [Abstract][Full Text] [Related]
13. Myc-mediated transcriptional repression by recruitment of histone deacetylase.
Kurland JF; Tansey WP
Cancer Res; 2008 May; 68(10):3624-9. PubMed ID: 18483244
[TBL] [Abstract][Full Text] [Related]
14. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
[TBL] [Abstract][Full Text] [Related]
15. AP4 encodes a c-MYC-inducible repressor of p21.
Jung P; Menssen A; Mayr D; Hermeking H
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310
[TBL] [Abstract][Full Text] [Related]
16. MAD1 and its life as a MYC antagonist: an update.
Lüscher B
Eur J Cell Biol; 2012; 91(6-7):506-14. PubMed ID: 21917351
[TBL] [Abstract][Full Text] [Related]
17. Gamma interferon induces expression of Mad1 gene in macrophage, which inhibits colony-stimulating factor-1-dependent mitogenesis.
Dey A; Kim L; Li W
J Cell Biochem; 1999 Feb; 72(2):232-41. PubMed ID: 10022505
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous knockdown of p18INK4C, p27Kip1 and MAD1 via RNA interference results in the expansion of long-term culture-initiating cells of murine bone marrow cells in vitro.
Wang YY; Yang Y; Chen Q; Yu J; Hou Y; Han L; He J; Jiao D; Yu H
Acta Biochim Biophys Sin (Shanghai); 2008 Aug; 40(8):711-20. PubMed ID: 18685787
[TBL] [Abstract][Full Text] [Related]
19. Neurokinin-A inhibits cell cycle activators in K562 cells and activates Smad 4 through a non-canonical pathway: a novel method in neural-hematopoietic axis.
Ricardo M; Trzaska KA; Rameshwar P
J Neuroimmunol; 2008 Nov; 204(1-2):85-91. PubMed ID: 18760489
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of myc promoter-binding protein 1 (MBP-1) in growth-arrested malignant B cells.
Tvrdík D; Dundr P; Povýsil C; Prikryl P; Melcáková S; Planková M
Folia Biol (Praha); 2007; 53(6):207-15. PubMed ID: 18070418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
